Kenneth Cornetta
Affiliations: | Microbiology & Immunology | Indiana University, Bloomington, Bloomington, IN, United States |
Area:
General Biology, Molecular BiologyGoogle:
"Kenneth Cornetta"Children
Sign in to add traineeChristoph A. Kahl | grad student | 2003 | Indiana University |
Guiandre L. Joseph | grad student | 2008 | Indiana University |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Reinhardt BC, Habib O, Shaw KL, et al. (2021) Long-term Outcomes after Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency (ADA SCID). Blood |
Scott M, Clarke D, Lipsitz Y, et al. (2020) Transitioning from development to commercial: risk-based guidance for critical materials management in cell therapies. Cytotherapy |
Cornetta KG, Rubin L, Long R, et al. (2020) The National Gene Vector Biorepository. Eleven Years of Providing Resources to the Gene Therapy Community. Human Gene Therapy |
Cornetta K, Koop S, Nance E, et al. (2020) Replication-Competent Lentivirus Analysis of Vector-Transduced T Cell Products Used in Cancer Immunotherapy Clinical Trials. Methods in Molecular Biology (Clifton, N.J.). 2086: 181-194 |
Cornetta K. (2019) Gene Transfer to HSCs: Finding the Leukemia in Murine Leukemia Viruses. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Kohn DB, Shaw KL, Garabedian E, et al. (2019) Lentiviral Gene Therapy with Autologous Hematopoietic Stem and Progenitor Cells (HSPCs) for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency (ADA-SCID): Results in an Expanded Cohort Blood. 134: 3345-3345 |
Cornetta K, Patel K, Wanjiku CM, et al. (2018) Equitable Access to Gene Therapy: A Call to Action for the American Society of Gene and Cell Therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Puig-Saus C, Parisi G, Garcia-Diaz A, et al. (2018) IND-enabling studies for a clinical trial to genetically program a persistent cancer-targeted immune system. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Cornetta K, Duffy L, Feldman SA, et al. (2018) Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience. Molecular Therapy. Methods & Clinical Development. 10: 371-378 |
Flotte TR, Daniels E, Benson J, et al. (2017) The Gene Therapy Resource Program: A Decade of Dedication to Translational Research by the National Heart, Lung, and Blood Institute. Human Gene Therapy. Clinical Development |